PF-7006

PF-7006 is a potent and selective Mps1 kinase inhibitor (Ki=0.27 nM) that disrupts mitotic checkpoints, leading to apoptosis in cancer cells. It has demonstrated efficacy in breast cancer research models, both in vitro and in vivo, and shows altered cellular tolerance when combined with agents like Palbociclib.